timolol has been researched along with Dermatoses in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Dany, M | 1 |
Dahle, SE; Gallegos, A; Isseroff, RR; Kaur, R; Schaefer, S; Tchanque-Fossuo, C; West, K; Yang, H; Yoon, DJ | 1 |
Ambrogio, F; Bonamonte, D; De Marco, A; Filoni, A; Pacifico, A | 1 |
Cohen, B; Jeon, H | 1 |
Baek, YS; Jeon, J; Kwon, SH | 1 |
Gupta, D; Singh, N; Thappa, DM | 1 |
Krol, A; Lofgren, S | 1 |
Van Buskirk, EM | 1 |
Kheradvar, A; Rad, AS | 1 |
Kershner, RM; Munroe, WP; Rindone, JP | 1 |
4 review(s) available for timolol and Dermatoses
Article | Year |
---|---|
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Trials as Topic; Granuloma, Pyogenic; Humans; Propranolol; Receptors, Adrenergic, beta; Recurrence; Skin; Skin Diseases; Timolol; Treatment Outcome | 2019 |
Topical beta-blockers in dermatologic therapy.
Topics: Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Sarcoma, Kaposi; Skin Diseases; Timolol | 2021 |
New therapies in pediatric dermatology.
Topics: Adrenergic beta-Antagonists; Child; Dermatitis, Atopic; Epidermolysis Bullosa Dystrophica; Etanercept; Hemangioma; Humans; Immunoglobulin G; Immunosuppressive Agents; Pediatrics; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Tacrolimus; Timolol; Ultraviolet Therapy; Vitamin D; Vitamins | 2011 |
Systemic side effects associated with the ophthalmic administration of timolol.
Topics: Absorption; Aged; Cardiovascular Diseases; Central Nervous System Diseases; Female; Humans; Kinetics; Lung Diseases; Ophthalmic Solutions; Skin Diseases; Timolol | 1985 |
6 other study(ies) available for timolol and Dermatoses
Article | Year |
---|---|
Adverse effects of topical timolol: Safety concerns and implications for dermatologic use.
Topics: Adrenergic beta-Antagonists; Drug-Related Side Effects and Adverse Reactions; Humans; Off-Label Use; Patient Selection; Skin Diseases; Timolol | 2021 |
Lack of efficacy of topical timolol for cutaneous telangiectasias in patients with hereditary hemorrhagic telangiectasia: Results of a pilot study.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Humans; Pilot Projects; Prospective Studies; Skin Diseases; Telangiectasia, Hereditary Hemorrhagic; Telangiectasis; Timolol; Treatment Failure | 2017 |
Combination of ligation and timolol before surgical excision of pyogenic granuloma.
Topics: Adolescent; Follow-Up Studies; Granuloma, Pyogenic; Humans; Ligation; Male; Preoperative Care; Skin Diseases; Timolol; Toes; Treatment Outcome | 2018 |
Is timolol an effective treatment for pyogenic granuloma?
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Granuloma, Pyogenic; Humans; Male; Middle Aged; Ophthalmic Solutions; Skin Diseases; Timolol; Young Adult | 2016 |
Adverse reactions from timolol administration.
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Corneal Diseases; Depression; Eye Diseases; Gastrointestinal Diseases; Glaucoma; Humans; Lung Diseases; Propanolamines; Skin Diseases; Timolol | 1980 |
Juvenile xanthogranuloma: concurrent involvement of skin and eye.
Topics: Acetazolamide; Atropine; Betamethasone; Drug Therapy, Combination; Eye Diseases; Humans; Infant; Intraocular Pressure; Male; Skin Diseases; Timolol; Xanthogranuloma, Juvenile | 2001 |